Form 4: ProAssurance Director Richard J. Bielen Reports Acquisition and Disposal of Shares

Sentiment:

SEC Form 4 Filing


Director Richard J. Bielen reports changes in beneficial ownership of ProAssurance Corp shares, including acquisition through director compensation plan and disposal.

Summary

  • Richard J. Bielen, a director of ProAssurance Corp, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
  • On May 21, 2025, Bielen acquired 4,101 shares of common stock at a price of $23.16 per share, awarded under the ProAssurance Corporation Director Deferred Stock Compensation Plan.
  • Bielen also disposed of 10,621 shares.
  • Following these transactions, Bielen directly owns 10,621 shares of ProAssurance Corp.
  • Bielen has granted power of attorney to Jeffrey P. Lisenby, Lee M. Pope, and Kathryn A. Neville to handle SEC filings related to ProAssurance Corp.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document primarily reports routine insider transactions without explicit positive or negative implications for the company's performance.

Positives

  • The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future.

Negatives

  • The disposal of 10,621 shares could be interpreted negatively, although the reason for disposal is not specified.

Risks

  • The Form 4 filing itself doesn't inherently present risks, but market perception of insider transactions can influence stock price.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance.

Management Comments

  • The Compensation Committee, composed of independent directors, recommended the stock compensation grant, which was approved by the Board of Directors.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies. These filings are closely watched by investors to gauge sentiment and potential future performance.

Comparison to Industry Standards

  • Director compensation plans involving stock grants are common across publicly traded companies, particularly in the insurance sector.
  • Companies like UnitedHealth Group, Anthem, and Cigna also utilize stock-based compensation for their directors.
  • The value of the stock grant ($95,000) is within a typical range for director compensation among similar-sized companies in the industry.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders' perception of the company, depending on how they interpret the director's stock activity.

Key Dates

DateDescription
May 22, 2024Date of Power of Attorney execution.
May 21, 2025Date of stock acquisition and disposal transaction.

Keywords

Form 4, ProAssurance, Director, Richard J. Bielen, Beneficial Ownership, Stock Compensation, Insider Trading, Shares

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.